Daniel Garcia, Counsel in Baker McKenzie’s Transactional Practice Group, co-authored an article for Springer Nature exploring the evolving legal framework for biomedical and pharmaceutical research conducted in space. Titled “At the Intersection of Law and Space Science: Bridging Gaps in the Current Legal Framework for Orbital Research, the article examines how existing international treaties and US laws apply to orbital research as activity expands beyond the International Space Station (ISS) to commercially operated platforms.
Using practical scenarios, Daniel analyzes key issues such as intellectual property ownership, data integrity and traceability, and the regulatory treatment of space-derived research used on Earth, noting that current laws were not designed for today’s operational realities. He also highlights that as the ISS nears decommissioning and private-sector activity accelerates the growing importance of contractual solutions to address legal uncertainty and support continued innovation, collaboration and trust in space-based research.
The full article is available here: At the Intersection of law and Space Science: Bridging gaps in the Current legal Framework for Orbital Research
Learn more: https://youtu.be/uQoxrIzzNK8?si=ludAWQu4aGYQJEqG
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Baker McKenzie Welcomes Cybersecurity and Data Privacy Attorney Katherine Hanniford in Washington, DC | 0 | 10 | 11-05-2026 |
| 2 | Baker McKenzie Advises Chemomab on Merger with Scipher Medicine | 0 | 10 | 10-07-2026 |
| 3 | Baker McKenzie Adds Leading FDA Partner Khelin Aiken and IP Counsel Rabiya Kader, Building on a Series of Strategic Hires Across the Global Life Sciences Platform | 0 | 10 | 21-07-2026 |
| 4 | The Convergence of Risk: Cyber, Data and AI Disputes | 0 | 10 | 15-06-2026 |
| 5 | Reaching the summit: IP STARS Americas rankings released | 0 | 9.22 | 30-07-2026 |
| 6 | Baker McKenzie Advises Bain Capital Life Sciences on Investment in Swixx BioPharma | 0 | 10 | 05-06-2026 |
| 7 | The Convergence of Risk: Antitrust Disputes | 0 | 10 | 30-06-2026 |
| 8 | Baker McKenzie advises on the sale of Vitabiotics to Bain Capital | 0 | 10 | 27-07-2026 |
| 9 | Japan: Antitrust Guidelines for IP and Data | 0 | 10 | 14-07-2026 |
| 10 | The future of AI in law: Trends and innovations to watch | 0 | 7 | 11-08-2025 |